Sign up to save your podcasts
Or
Share Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost
Interview with Alyssa Burgart, MD, MA, author of Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy, and Vinay Prasad, author of Nusinersen for Spinal Muscular Atrophy: Are We Paying Too Much for Too Little?
View all episodes
By JAMA Network
4.2
99 ratings
Interview with Alyssa Burgart, MD, MA, author of Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy, and Vinay Prasad, author of Nusinersen for Spinal Muscular Atrophy: Are We Paying Too Much for Too Little?
More shows like JAMA Pediatrics Author Interviews
View all
JAMA Clinical Reviews
497 Listeners
JAMA Author Interviews
162 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
JAMA Psychiatry Author Interviews
21 Listeners
JAMA Neurology Author Interviews
12 Listeners
JAMA Oncology Author Interviews
11 Listeners
JAMA Cardiology Author Interviews
9 Listeners
JAMA Dermatology Author Interviews
16 Listeners
JAMA Internal Medicine Author Interviews
19 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
7 Listeners
JAMAevidence The Rational Clinical Examination
30 Listeners
JAMA Medical News
92 Listeners
JAMAevidence Users' Guides to the Medical Literature
14 Listeners
JAMAevidence Care at the Close of Life
5 Listeners
JAMA Network Open Conversations
5 Listeners
Coronavirus (COVID-19) Q&A
106 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
JAMA Health Forum Conversations
3 Listeners